Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1405347

C[n+]1ccc(-c2ccncc2)cc1.Cl.[Cl-]

nearest known ligand 0.91

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ SLC6A4 known ✓ P31645 1/20 0.54
▸ HDAC8 known ✓ Q9BY41 2/20 0.40
▸ PABPC1 P11940 1/20 0.91
▸ APOBEC3A P31941 1/20 0.91
▸ EIF4H Q15056 1/20 0.91
▸ APOBEC3G Q9HC16 1/20 0.91
▸ MAPT P10636 2/20 0.55
▸ LMNA P02545 1/20 0.55
▸ SLC22A2 O15244 1/20 0.54
▸ SLC22A1 O15245 1/20 0.54
▸ SLC22A3 O75751 1/20 0.54
▸ NOTUM Q6P988 1/20 0.46
▸ QDPR P09417 2/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ KIF11 P52732 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28126821 1.00 PABPC1 (0.91) PABPC1APOBEC3AEIF4HAPOBEC3GMAPT
Hydrochloric Acid SCHEMBL27906760 0.98 PABPC1 (0.86) PABPC1APOBEC3AEIF4HAPOBEC3GMAPT
SCHEMBL2819725 0.97 PABPC1 (0.95) PABPC1APOBEC3AEIF4HAPOBEC3GMAPT
Hydrochloric Acid SCHEMBL11471102 0.97 PABPC1 (0.95) PABPC1APOBEC3AEIF4HAPOBEC3GMAPT
Iodide SCHEMBL7138780 0.95 PABPC1 (1.00) PABPC1APOBEC3AEIF4HAPOBEC3GMAPT
Iodide SCHEMBL2817451 0.93 PABPC1 (0.95) PABPC1APOBEC3AEIF4HAPOBEC3GMAPT
SCHEMBL18015924 0.91 PABPC1 (0.83) PABPC1APOBEC3AEIF4HAPOBEC3GMAPT
Paraquat SCHEMBL6054874 0.87 SLC6A4 (0.68) PABPC1APOBEC3AEIF4HAPOBEC3GSLC22A2
Paraquat SCHEMBL30968908 0.87 SLC6A4 (0.68) PABPC1APOBEC3AEIF4HAPOBEC3GSLC22A2
Paraquat SCHEMBL9650240 0.84 SLC6A4 (0.72) PABPC1APOBEC3AEIF4HAPOBEC3GSLC22A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240002621-A1 eTPE Laser Marking BASF SE (DE) 2024-01-04 — — US disclosed
EP-4221986-A1 ETPE LASER MARKING BASF SE (DE) 2023-08-09 — — EP disclosed
US-10323989-B2 Advanced multi-element consumable-disposable products SEGAN INDUSTRIES, INC. (US) 2019-06-18 — — US disclosed
US-9868873-B2 Photochromic security enabled ink for digital offset printing applications XEROX CORPORATION (US) 2018-01-16 — — US disclosed
US-20180003565-A1 Advanced Multi-Element Consumable-Disposable Products SEGAN INDUSTRIES, INC. 2018-01-04 — — US disclosed
CN-107164376-A Use the method for the VLP with the capsid to hydrolytic enzyme resistant 阿普斯有限责任公司 2017-09-15 — — CN disclosed
US-9746380-B2 Advanced multi-element consumable-disposable products SEGAN INDUSTRIES, INC. (US) 2017-08-29 — — US disclosed
CN-103113876-B Photochromic optomagnetic material 中国科学院福建物质结构研究所 2017-02-08 — — CN disclosed
US-9404001-B2 Photochromic latex ink XEROX CORPORATION (US) 2016-08-02 — — US disclosed
US-20150153479-A1 PHOTOCHROMIC LATEX INK XEROX CORPORATION (US) 2015-06-04 — — US disclosed
US-7202006-B2 Protective layer for reimageable medium XEROX CORPORATION (US) 2007-04-10 — — US disclosed
US-20070003847-A1 Protective layer for reimageable medium XEROX CORPORATION 2007-01-04 — — US disclosed
US-20060222973-A1 Multicolor electronic paper XEROX CORPORATION 2006-10-05 — — US disclosed
CN-1790772-A Patterned substrate, electro-optical device, and method for manufacturing an electro-optical device SEIKO EPSON CORP (JP) 2006-06-21 — — CN disclosed
US-20050244742-A1 Reimageable medium with light absorbing material XEROX CORPORATION 2005-11-03 — — US disclosed
US-20050244744-A1 Method for forming temporary image XEROX CORPORATION 2005-11-03 — — US disclosed
US-20050244743-A1 Reimageable medium XEROX CORPORATION. 2005-11-03 — — US disclosed
EP-1591830-A2 Reimageable medium Xerox Corporation (US) 2005-11-02 — — EP disclosed
EP-1591831-A2 Reimageable medium with light absorbing material Xerox Corporation (US) 2005-11-02 — — EP disclosed
EP-1591829-A1 Method for forming temporary image Xerox Corporation (US) 2005-11-02 — — EP disclosed
Send feedback